Avid Bioservices Inc (CDMO)

[swg_tdr]

CJ, thanks. Not best-worded PR and subsequent Reuters' quote, IMO

"...show that patients lived about 3 1/2 times as long as would be expected if they were left untreated, according to the company.
Peregrine said the trial's first 14 patients lived a median of 86 weeks, compared with expected survival of about 24 weeks for patients whose cancer has recurred"

AND MIGHT HAVE ADDED after Best of Practice Current Care IMHO. First para in PR carries!

if they can screw up, they will - at least we have a better PennyPay report

regards,
NHwild

PS thanks for your #57487, appreciated